Valproic acid alters mitochondrial cholesterol transport in Y1 adrenocortical cells
Authors:
- F. Cornejo MacielFMF. Cornejo Maciel
- C. PazCPC. Paz
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Toxicology in Vitro
- Vol. 25 (1) , 7-12
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The metabolic syndrome in overweight epileptic patients treated with valproic acidEpilepsia, 2010
- Steroidogenic Activity of StAR Requires Contact with Mitochondrial VDAC1 and Phosphate Carrier ProteinJournal of Biological Chemistry, 2008
- Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitorsBiochemical and Biophysical Research Communications, 2008
- A Mitochondrial Kinase Complex Is Essential to Mediate an ERK1/2-Dependent Phosphorylation of a Key Regulatory Protein in Steroid BiosynthesisPLOS ONE, 2008
- Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)Molecular and Cellular Biology, 2007
- cAMP increases mitochondrial cholesterol transport through the induction of arachidonic acid release inside this organelle in Leydig cellsThe FEBS Journal, 2006
- Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat HepatocytesToxicological Sciences, 2005
- An arachidonic acid-preferring acyl-CoA synthetase is a hormone-dependent and obligatory protein in the signal transduction pathway of steroidogenic hormonesJournal of Molecular Endocrinology, 2005
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970